Bausch + Lomb Corp.

Organisation

520 Applewood Crescent, Vaughan, ON, Canada, L4K 4B4

Headquarters

13000

Employees

Healthcare

Industry

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provide optical correction during healing. It also offers contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. The Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.

Price

Target

Bausch + Lomb Corp. (BLCO) Price vs Consensus Price Target

As per the chart shown above, analysts believe that the Bausch + Lomb Corp. (BLCO) share price will touch around $18.46 in next 12-months.

Currently 18 wall-street analysts regularly analyze the financials of Bausch + Lomb Corp. on a frequent basis to provide recommendations along with target share price. 18 analysts offering 12-month price forecasts for Bausch + Lomb Corp. (BLCO) have a share price target of $18.46. This median of share price forecast represents a 12.02% upside from the latest price of $16.48 as on 06.04.26.

Bausch + Lomb Corp. (BLCO) Share Price Forecast

Home

US Stocks

Bausch + Lomb Corp. (BLCO)

Bausch + Lomb Corp. Stock Forecast

Bausch + Lomb Corp. Stock Forecast & Price Target (Analyst Recommendation) | INDmoney

Percentage Difference

Bausch + Lomb Corp. (BLCO): Difference between Current Price & Median Forecasted Price

Below is a chart showing the percentage difference between Bausch + Lomb Corp.'s share price and its median forecast price. As on 06.04.26, the difference is -9.65%

Bausch + Lomb Corp. Forecast and Target Price

Bausch + Lomb Corp. (BLCO) Share Price Forecast

Bausch + Lomb Corp. (BLCO) Price vs Consensus Price Target

Bausch + Lomb Corp. (BLCO) Share Price Forecast v/s Share Price Today

Bausch + Lomb Corp. (BLCO): Difference between Current Price & Median Forecasted Price

Bausch + Lomb Corp. (BLCO) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

200 Day Moving Average v/s Current Share Price